Literature DB >> 22247450

Future directions in mucormycosis research.

Dimitrios P Kontoyiannis1, Russell E Lewis, Oliver Lortholary, Oliver Lotholary, Brad Spellberg, Georgios Petrikkos, Emmanuel Roilides, Emmanuel Roillides, Ashraf Ibrahim, Thomas J Walsh.   

Abstract

Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22247450      PMCID： PMC3258101          DOI： 10.1093/cid/cir886

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  59 in total

1.  Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination.

Authors:  Jeffrey J Tarrand; Mathias Lichterfeld; Irfan Warraich; Mario Luna; Xiang Y Han; Gregory S May; Dimitrios P Kontoyiannis
Journal:  Am J Clin Pathol       Date:  2003-06       Impact factor: 2.493

2.  Zygomycosis in the 1990s in a tertiary-care cancer center.

Authors:  D P Kontoyiannis; V C Wessel; G P Bodey; K V Rolston
Journal:  Clin Infect Dis       Date:  2000-06-13       Impact factor: 9.079

Review 3.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

5.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

6.  In vitro susceptibilities of zygomycetes to conventional and new antifungals.

Authors:  Eric Dannaoui; Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

7.  Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.

Authors:  Paul A Mann; Raulo M Parmegiani; Shui-Qing Wei; Cara A Mendrick; Xin Li; David Loebenberg; Beth DiDomenico; Roberta S Hare; Scott S Walker; Paul M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.

Authors:  W M Artis; J A Fountain; H K Delcher; H E Jones
Journal:  Diabetes       Date:  1982-12       Impact factor: 9.461

Review 9.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

Review 10.  Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella.

Authors:  K Kamei
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785
View more
  14 in total

Review 1.  Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.

Authors:  David J Epstein; Susan K Seo; Janice M Brown; Genovefa A Papanicolaou
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

2.  Serial monitoring of Mucorales DNA load in serum samples of a patient with disseminated mucormycosis after allogeneic bone marrow transplantation.

Authors:  Tomonari Shigemura; Yozo Nakazawa; Kazuyuki Matsuda; Kenji Sano; Takashi Yaguchi; Mitsuo Motobayashi; Shoji Saito; Shunsuke Noda; Norimoto Kobayashi; Kazunaga Agematsu; Takayuki Honda; Kenichi Koike
Journal:  Int J Hematol       Date:  2014-05-22       Impact factor: 2.490

3.  Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.

Authors:  Anne-Pauline Bellanger; Alexander M Tatara; Fazal Shirazi; Teclegiorgis Gebremariam; Nathaniel D Albert; Russell E Lewis; Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2016-03-16       Impact factor: 5.226

4.  Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis.

Authors:  Joana Cortez; Bruno Costa Gomes; Andrea Speidel; Conceição Peixoto; Elina Selicka; Cristina Valente; Paulo Figueiredo; António Vieira
Journal:  Med Mycol Case Rep       Date:  2013-03-14

5.  Emerging invasive fungal diseases in transplantation.

Authors:  Perrine Parize; Blandine Rammaert; Olivier Lortholary
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

6.  Mucorales-Specific T Cells in Patients with Hematologic Malignancies.

Authors:  Leonardo Potenza; Daniela Vallerini; Patrizia Barozzi; Giovanni Riva; Andrea Gilioli; Fabio Forghieri; Anna Candoni; Simone Cesaro; Chiara Quadrelli; Johan Maertens; Giulio Rossi; Monica Morselli; Mauro Codeluppi; Cristina Mussini; Elisabetta Colaci; Andrea Messerotti; Ambra Paolini; Monica Maccaferri; Valeria Fantuzzi; Cinzia Del Giovane; Alessandro Stefani; Uliano Morandi; Rossana Maffei; Roberto Marasca; Franco Narni; Renato Fanin; Patrizia Comoli; Luigina Romani; Anne Beauvais; Pier Luigi Viale; Jean Paul Latgè; Russell E Lewis; Mario Luppi
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

7.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

8.  Tuberculosis of Lymph Node Combined with Pulmonary Mucormycosis.

Authors:  Shan Yu; Hong-Bing Chen
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

9.  Management of a Case of Mucor Colonization in Breast Tissue Expander Seroma Pocket.

Authors:  Danielle N Atwood; Pallavi A Kumbla; Brian Yuen; James C Yuen
Journal:  World J Plast Surg       Date:  2018-01

Review 10.  A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare.

Authors:  Kathleen P Hartnett; Brendan R Jackson; Kiran M Perkins; Janet Glowicz; Janna L Kerins; Stephanie R Black; Shawn R Lockhart; Bryan E Christensen; Karlyn D Beer
Journal:  J Fungi (Basel)       Date:  2019-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.